Biocryst pharmaceuticals drug approved for sale in europe

BCRX's Drug (Orladeyo) was recently approved by the european commission for sale in europe :

European Approval document: https://www.ema.europa.eu/en/medicines/human/summaries-opinion/orladeyo-0

wiki page on the drug: https://en.wikipedia.org/wiki/Berotralstat

This was previously only available in the US via prescription.

Access to additional markets should be healthy for the companies' balance sheet.

My plan:
Short term:
Change in sentiment is a good short term trade:

Short term play:
Bull debit option spread:

long May 21st $12 CALL
Short May 21st $15 CALL

Long term play:

Buy and hold 100 shares, sell 45 DTE covered calls against these shares, planning to hold for a period of 2-4 years if my outlook remains bullish .

I will review earnings calls, cash flows and balance sheets and review my sentiment after each quarter.